Description

Retatrutide is a synthetic triple-agonist peptide targeting the GLP-1, GIP, and glucagon receptor pathways. It is supplied as a lyophilized powder for quantification, handling, and analytical characterization in laboratory settings. This bulk option includes ten (10) vials. Each vial contains 30mg of high-purity material intended for laboratory and in-vitro research applications only.